| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.29 | 0.06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |